Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Vaccine: multipeptide cocktail suits patients
New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.
Related Videos
Related Content
